WHAT'S CONFIRMED
- ▸The vaccine reduced cancer recurrence and death risk by 42% compared with standard treatment. — NBC News Health, CNBC
NOT REPORTED ELSEWHERE
- ▸Six melanoma specialists called the results clinically meaningful for post-surgery melanoma patients. — CNBC